Dr. Lee on the Importance of Collaboration in Precision Medicine

Video

In Partnership With:

Kelvin P. Lee, MD, discusses the importance of collaboration in precision medicine.

Kelvin P. Lee, MD, senior associate dean of Cancer Research, director, Indiana University (IU) Simon Comprehensive Cancer Center, H.H. Gregg professor of oncology, member, the Department of Medicine, the Department of Microbiology and Immunology, IU School of Medicine, Indiana University Health, discusses the importance of collaboration in precision medicine.

At the IU Simon Comprehensive Cancer Center, a precision medicine team takes patient referrals to receive testing and sequencing, Lee says. The team then analyzes the results to identify abnormalities and mutations that could lead to actionable treatment, Lee adds. This process is beneficial because multiple experts gather in one room to discuss the best course of action, Lee explains.

With the addition of a virtual option for these meetings, there is the benefit of adding moving precision medicine out into the community, Lee continues. Utilizing the virtual option can allow the team to reach more patients, plus more primary care physicians or community oncologists, to get referrals and assist in treatment decisions, Lee concludes.

Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine